Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2011/0301233 Novel Polyisoprenylated Benzophenone Derivatives from Garcinia paucinervis
Novel polyisoprenylated benzophenone derivatives isolated from the plant Garcinia paucinervis. Among these new compounds, paucinones A-C (Compounds 1-3)...
2011/0301232 PROCESS OF EXTRACTING PROCYANIDINS BY ALKALINE HYDROLYSIS
A process of extracting procyanidins by alkaline hydrolysis. In particular, a procyanidin-containing material, pomace or residue is treated with an alkali, such...
2011/0301231 LIPASE INHIBITING COMPOSITION
Pharmaceutical compositions that contain a lipase inhibitor having a melting point .gtoreq.37.degree. C., a sucrose fatty acid ester wherein the sucrose fatty...
2011/0301230 GENE CARRIER
Disclosed is a gene carrier composed of a hydrogen-bonding polymer having a polymer chain with hydrogen-bonding sites formed on the polymer chain, in which the...
2011/0301229 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as...
2011/0301228 GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA
The presently disclosed subject matter provides an inducible vector comprising a therapeutic gene. In some embodiments a method is provided for treating steroid...
2011/0301227 PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS
This application relates to the use of agents such as expression vectors and nucleic acids encoding integrins .alpha.6A or .alpha.6B as well as antibodies...
2011/0301226 COMPOSITIONS AND METHODS FOR TREATING HEPATIC NEOPLASIA
The present invention provides compositions and methods featuring miR-26 microRNA polynucleotides for the diagnosis, treatment or prevention of hepatic neoplasia.
2011/0301225 Compounds and Methods for Reducing the Recruitment and/or Migration of Polymorphonuclear Cells
A therapeutically effective amount of an oligonucleotide is capable of influencing the properties and behaviour of polymorphonuclear cells, e.g. suppressing...
2011/0301224 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
The invention provides compositions and methods for selectively reducing the expression of a gene product from a desired target gene, as well as treating...
2011/0301223 COMPOSITIONS AND METHODS FOR INSECTICIDAL CONTROL OF STINKBUGS
Methods and compositions are provided which employ a silencing element that, when ingested by a pest, such as a Pentatomidae plant pest or a N. viridula,...
2011/0301222 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
The present invention provides methods of sensitizing cancer cells to docetaxel and inhibiting the growth of various tumors by employing a modified eIF-4E...
2011/0301221 DIAGNOSIS, PROGNOSIS AND TREATMENT OF GLIOBLASTOMA MULTIFORME
The present invention in one aspect relates generally to the identification, provision and use of a plurality of biomarkers to provide risk assessment of a...
2011/0301220 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC...
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic,...
2011/0301219 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC...
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic,...
2011/0301218 MODIFIED snRNAs FOR USE IN THERAPY
The invention relates to a nucleic acid encoding a small nuclear RNA (snRNA), which snRNA is modified so that it contains sequence capable of hybridizing with...
2011/0301217 Selective Glycosidase Inhibitors and Uses Thereof
The application relates to an immoalditol compound for selectively inhibiting glycosidases, a prodrug thereof and a pharmaceutical composition comprising the...
2011/0301216 ANTICANCER AND ANTIMICROBIAL COMPOUNDS FROM ANTARCTIC EXTREMOPHILIC MICROORGANSIMS
The present disclosure describes the isolation of extremophilic microorganisms from the Lakes of Schirmacher Oasis located in the East Antarctic Dronning Maud...
2011/0301215 INHIBITORS OF PLASMA KALLIKREIN
The present invention provides compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating the formation of thrombin...
2011/0301214 PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
Disclosed herein is a pharmaceutical composition comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol and methods of using the composition to treat...
2011/0301213 USE OF PILOCARPINE FOR HYPOPTYALISM TREATMENT
A method of treating hypoptyalism in a subject is provided. The method includes administering to the subject a pharmaceutical composition that includes...
2011/0301212 METHOD FOR TREATING PROLIFERATIVE DISORDERS ASSOCIATED WITH PROTOONCOGENE PRODUCTS
The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating Bcr-Abl, FLT-3, EGFR, c-Kit,...
2011/0301211 ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include...
2011/0301210 USE OF PRAMIPEXOLE TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
The present invention is directed to compositions comprising pramipexole and the use of such compositions to treat neurodegenerative diseases such as...
2011/0301209 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS, AND TUMOR-RELATED DISORDERS
Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
2011/0301208 VIRAL AND FUNGAL INHIBITORS
Novel classes of viral and fungal inhibitors are disclosed. These compounds are useful in treating, preventing, and/or ameliorating viral infections such as,...
2011/0301207 METHODS AND SUSTAINED RELEASE NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA
An orally administered antihyperlipidemia composition according to the present invention includes from about 250 to about 3000 parts by weight of nicotinic...
2011/0301206 SYNERGISTIC PRESERVATIVE BLENDS
The present invention is a preservative formulation which includes a combination of at least two (2) compounds having bactericidal and/or fungicidal properties...
2011/0301205 ISOXAZOLE DERIVATIVES FOR USE AS FUNGICIDES
The present invention relates to isoxazole compounds of formula (I) having fungicidal activity, to agricultural compositions comprising them, and to the use of...
2011/0301204 ADMINISTRATION REGIME FOR NITROCATECHOLS
The present invention relates to novel dosage regimens for compounds of formula I: where the substituents are as defined in the specification.
2011/0301203 CHEMICAL COMPOUNDS
This invention relates to non-steroidal compounds that are modulators of androgen receptor, and also to the methods for the making and use of such compounds.
2011/0301202 SPLA2 INHIBITOR CONJUGATE COMPOUNDS AND METHODS OF USE
The present application provides a novel set of compounds comprising a sPLA.sub.2 inhibitor conjugated to a niacin drug, as well as kits containing these...
2011/0301201 DABIGATRAN FOR PERCUTANEOUS INTERVENTIONAL CARDIAC CATHETERISATION
The invention relates to a new use of dabigatran etexilate of formula (I) optionally in the form of the pharmaceutically acceptable salts thereof, and new...
2011/0301200 THYROID RECEPTOR LIGANDS
The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone...
2011/0301199 COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME
This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for...
2011/0301198 COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME
This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for...
2011/0301197 Bis(difluoromethyl)pyrazoles as Fungicides
Bis(difluoromethyl)pyrazole derivatives of the formula (I) ##STR00001## in which the symbols R.sup.1, X, Y and Q are each as defined in the description, and...
2011/0301196 TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USE
The invention provides compounds that are effective as inhibitors of human plasmin and plasma kallikrein, and that are useful for the prevention of blood loss...
2011/0301195 TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE
The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable...
2011/0301194 Method for Determining Treatment Efficacy
The present invention provides a method for determining the efficacy of a c-Met inhibitor in treating a cell proliferative disorder, comprising: a) ...
2011/0301193 METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT
Provided herein are compounds having anti-proliferative effect. Also provided are compounds that can modulate the activity of multi-domain proteins comprising a...
2011/0301192 Inhibitors of Cyclin Kinase Inhibitor p21
The present invention provides compounds that inhibit cyclin kinase inhibitor p21, such as compounds of formula I. The present invention also provides...
2011/0301191 METHODS OF TREATMENT USING SELECTIVE 5-HT2A INVERSE AGONISTS
Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In...
2011/0301190 POLYMORPHIC FORMS OF A GABAA AGONIST
The present invention is directed to novel polymorphic forms of the compound 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrate (gaboxadol monohydrate). The...
2011/0301189 STABLE PHARMACEUTICAL COMPOSITIONS OF RAPAMYCIN ESTERS
A stable pharmaceutical compositions of Rapamycin Esters, in particular Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid that is free...
2011/0301188 Synergistic Effects Between Sphingosine-1-Phosphate Receptor Antagonists and Antimicrotubule Agents
This invention is based on the discovery that the administration of a sphingosine-1-phosphate receptor antagonist (S1P) and at least one chemotherapeutic agent...
2011/0301187 BIS [O-(14-BENZOYLACONINE-8-YL)] ESTERS
The present invention concerns novel compounds having the structure (I). Another object of the invention is the use of compounds (I) for the fabrication of a...
2011/0301186 USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
This invention is directed to methods and compositions for the treatment of cardiovascular disorders. Specifically, the invention is directed to compositions...
2011/0301185 CANCER TREATMENT METHOD
The present invention relates to a method of treating cancer in a mammal by administration of 4-quinazolinamines and at least one additional anti-neoplastic...
2011/0301184 PHARMACEUTICAL COMBINATIONS COMPRISING A MTOR INHIBITOR AND A RAF KINASE INHIBITOR
A pharmaceutical combination comprising an mTOR inhibitor and a Raf kinase inhibitor and its use.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.